Table 1b.
Patient demographics and baseline characteristics in Henan cohort.
| All Cases (N = 51) | Mild (N = 12) | Moderate (N = 25) | Severe (N = 14) | |
|---|---|---|---|---|
| Gender, n (%) | ||||
| Male | 21(41.18%) | 5(41.67%) | 10(40%) | 6(42.86%) |
| Female | 30(58.82%) | 7(58.33%) | 15(60%) | 8(57.14%) |
| Age (years) | ||||
| Mean ± SD | 67.63±17.21 | 70.25±17.35 | 60.08±16.25 | 78.86±12.05 |
| Median | 69 | 73.5 | 65 | 81 |
| Min: Max | 25:98 | 25:89 | 32:88 | 48:98 |
| Age group, n (%) | ||||
| <65 years | 16(31.37%) | 3(25%) | 12(48%) | 1(7.14%) |
| 65≤age<75 | 16(31.37%) | 4(33.33%) | 9(36%) | 3(21.43%) |
| 75≤age<85 | 12(23.53%) | 3(25%) | 3(12%) | 6(42.86%) |
| ≥85 years | 7(13.73%) | 2(16.67%) | 1(4%) | 4(28.57%) |
| Variant strains, n (%) | ||||
| Delta | 47(92.16%) | 11(91.67%) | 23(92%) | 13(92.86%) |
| Omicron | 4(7.84%) | 1(8.33%) | 2(8%) | 1(7.14%) |
| Symptom onset to treatment (days) | ||||
| Number of cases | N = 41 | N = 9 | N = 22 | N = 10 |
| Mean ± SD | 8.41±3.75 | 8.22±3.67 | 8.36±4.19 | 8.7±3.09 |
| Median | 8 | 8 | 7 | 9 |
| Min: Max | 2:15 | 3:14 | 2:15 | 3:13 |
*The most severe stage experienced by patient was used as the diagnostic type (mild, moderate, severe).